Latest filing published 26 Sept 2014 for International Stem Cell CORP, €784.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -70.4%Entry US$13.50 · Close at T+365 US$4.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tibor Jay Novak: trading record in brief
Tibor Jay Novak discloses dealings in International Stem Cell Corp to SEC (Form 4). In total, 4 filings cover trades dated from 29 August 2014 to 10 October 2014.
Every open-market trade on record is a purchase: 4 purchases worth €3,104, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Half of the purchases are above €779 and half below.
Most recently, on 10 October 2014, the filings show an open-market purchase worth €788 in International Stem Cell Corp. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tibor Jay Novak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.10Common StockSEC:0001019687-14-003722:0Canonical exit: 25 Dec 2014 (T+90)
1 of 1 declaration